Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank86
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-67.85M
↑ 40% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-112.32M
Historical baseline
PeriodValueYoY Change
2025$-67.85M+62.0%
2024$-178.78M-10.4%
2023$-161.90M-82.2%
2022$-88.85M-2.1%
2021$-87.02M+39.1%
2020$-142.97M-225.6%
2019$113.81M+176.6%
2018$-148.61M+19.8%
2017$-185.39M-5.6%
2016$-175.63M-